Report Detail
Global Etoposide Soft Capsules Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4736332 |
- 24 August, 2026 |
- Global |
- 78 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Etoposide Soft Capsules market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Etoposide (also commonly known as VP-16) is a semisynthetic derivative of podophyllotoxin used in the treatment of certain neoplastic diseases(such as small cell lung cancer). Etoposide works by slowing the growth of cancer cells. Etoposide is also indicated in combination with other approved chemotherapeutic agents for the treatment of small-cell lung cancer in adults.
This report is a detailed and comprehensive analysis for global Etoposide Soft Capsules market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Etoposide Soft Capsules market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Etoposide Soft Capsules market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Etoposide Soft Capsules market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Etoposide Soft Capsules market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Etoposide Soft Capsules
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Etoposide Soft Capsules market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol-Myers Squibb, Nippon Kayaku, Xediton Pharmaceuticals, Jiangsu Hengrui Medicine, Taj Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Etoposide Soft Capsules market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
25mg
50mg
Market segment by Application
Small Cell Lung Cancer
Malignant Lymphoma
Malignant Germ Cell Tumor
Others
Major players covered
Bristol-Myers Squibb
Nippon Kayaku
Xediton Pharmaceuticals
Jiangsu Hengrui Medicine
Taj Pharma
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Etoposide Soft Capsules product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Etoposide Soft Capsules, with price, sales quantity, revenue, and global market share of Etoposide Soft Capsules from 2021 to 2026.
Chapter 3, the Etoposide Soft Capsules competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Etoposide Soft Capsules breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Etoposide Soft Capsules market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Etoposide Soft Capsules.
Chapter 14 and 15, to describe Etoposide Soft Capsules sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Etoposide Soft Capsules Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 25mg
- 1.3.3 50mg
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Etoposide Soft Capsules Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Small Cell Lung Cancer
- 1.4.3 Malignant Lymphoma
- 1.4.4 Malignant Germ Cell Tumor
- 1.4.5 Others
- 1.5 Global Etoposide Soft Capsules Market Size & Forecast
- 1.5.1 Global Etoposide Soft Capsules Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Etoposide Soft Capsules Sales Quantity (2021-2032)
- 1.5.3 Global Etoposide Soft Capsules Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Bristol-Myers Squibb
- 2.1.1 Bristol-Myers Squibb Details
- 2.1.2 Bristol-Myers Squibb Major Business
- 2.1.3 Bristol-Myers Squibb Etoposide Soft Capsules Product and Services
- 2.1.4 Bristol-Myers Squibb Etoposide Soft Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Bristol-Myers Squibb Recent Developments/Updates
- 2.2 Nippon Kayaku
- 2.2.1 Nippon Kayaku Details
- 2.2.2 Nippon Kayaku Major Business
- 2.2.3 Nippon Kayaku Etoposide Soft Capsules Product and Services
- 2.2.4 Nippon Kayaku Etoposide Soft Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Nippon Kayaku Recent Developments/Updates
- 2.3 Xediton Pharmaceuticals
- 2.3.1 Xediton Pharmaceuticals Details
- 2.3.2 Xediton Pharmaceuticals Major Business
- 2.3.3 Xediton Pharmaceuticals Etoposide Soft Capsules Product and Services
- 2.3.4 Xediton Pharmaceuticals Etoposide Soft Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Xediton Pharmaceuticals Recent Developments/Updates
- 2.4 Jiangsu Hengrui Medicine
- 2.4.1 Jiangsu Hengrui Medicine Details
- 2.4.2 Jiangsu Hengrui Medicine Major Business
- 2.4.3 Jiangsu Hengrui Medicine Etoposide Soft Capsules Product and Services
- 2.4.4 Jiangsu Hengrui Medicine Etoposide Soft Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Jiangsu Hengrui Medicine Recent Developments/Updates
- 2.5 Taj Pharma
- 2.5.1 Taj Pharma Details
- 2.5.2 Taj Pharma Major Business
- 2.5.3 Taj Pharma Etoposide Soft Capsules Product and Services
- 2.5.4 Taj Pharma Etoposide Soft Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Taj Pharma Recent Developments/Updates
3 Competitive Environment: Etoposide Soft Capsules by Manufacturer
- 3.1 Global Etoposide Soft Capsules Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Etoposide Soft Capsules Revenue by Manufacturer (2021-2026)
- 3.3 Global Etoposide Soft Capsules Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Etoposide Soft Capsules by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Etoposide Soft Capsules Manufacturer Market Share in 2025
- 3.4.3 Top 6 Etoposide Soft Capsules Manufacturer Market Share in 2025
- 3.5 Etoposide Soft Capsules Market: Overall Company Footprint Analysis
- 3.5.1 Etoposide Soft Capsules Market: Region Footprint
- 3.5.2 Etoposide Soft Capsules Market: Company Product Type Footprint
- 3.5.3 Etoposide Soft Capsules Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Etoposide Soft Capsules Market Size by Region
- 4.1.1 Global Etoposide Soft Capsules Sales Quantity by Region (2021-2032)
- 4.1.2 Global Etoposide Soft Capsules Consumption Value by Region (2021-2032)
- 4.1.3 Global Etoposide Soft Capsules Average Price by Region (2021-2032)
- 4.2 North America Etoposide Soft Capsules Consumption Value (2021-2032)
- 4.3 Europe Etoposide Soft Capsules Consumption Value (2021-2032)
- 4.4 Asia-Pacific Etoposide Soft Capsules Consumption Value (2021-2032)
- 4.5 South America Etoposide Soft Capsules Consumption Value (2021-2032)
- 4.6 Middle East & Africa Etoposide Soft Capsules Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Etoposide Soft Capsules Sales Quantity by Type (2021-2032)
- 5.2 Global Etoposide Soft Capsules Consumption Value by Type (2021-2032)
- 5.3 Global Etoposide Soft Capsules Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Etoposide Soft Capsules Sales Quantity by Application (2021-2032)
- 6.2 Global Etoposide Soft Capsules Consumption Value by Application (2021-2032)
- 6.3 Global Etoposide Soft Capsules Average Price by Application (2021-2032)
7 North America
- 7.1 North America Etoposide Soft Capsules Sales Quantity by Type (2021-2032)
- 7.2 North America Etoposide Soft Capsules Sales Quantity by Application (2021-2032)
- 7.3 North America Etoposide Soft Capsules Market Size by Country
- 7.3.1 North America Etoposide Soft Capsules Sales Quantity by Country (2021-2032)
- 7.3.2 North America Etoposide Soft Capsules Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Etoposide Soft Capsules Sales Quantity by Type (2021-2032)
- 8.2 Europe Etoposide Soft Capsules Sales Quantity by Application (2021-2032)
- 8.3 Europe Etoposide Soft Capsules Market Size by Country
- 8.3.1 Europe Etoposide Soft Capsules Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Etoposide Soft Capsules Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Etoposide Soft Capsules Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Etoposide Soft Capsules Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Etoposide Soft Capsules Market Size by Region
- 9.3.1 Asia-Pacific Etoposide Soft Capsules Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Etoposide Soft Capsules Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Etoposide Soft Capsules Sales Quantity by Type (2021-2032)
- 10.2 South America Etoposide Soft Capsules Sales Quantity by Application (2021-2032)
- 10.3 South America Etoposide Soft Capsules Market Size by Country
- 10.3.1 South America Etoposide Soft Capsules Sales Quantity by Country (2021-2032)
- 10.3.2 South America Etoposide Soft Capsules Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Etoposide Soft Capsules Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Etoposide Soft Capsules Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Etoposide Soft Capsules Market Size by Country
- 11.3.1 Middle East & Africa Etoposide Soft Capsules Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Etoposide Soft Capsules Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Etoposide Soft Capsules Market Drivers
- 12.2 Etoposide Soft Capsules Market Restraints
- 12.3 Etoposide Soft Capsules Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Etoposide Soft Capsules and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Etoposide Soft Capsules
- 13.3 Etoposide Soft Capsules Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Etoposide Soft Capsules Typical Distributors
- 14.3 Etoposide Soft Capsules Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Etoposide Soft Capsules. Industry analysis & Market Report on Etoposide Soft Capsules is a syndicated market report, published as Global Etoposide Soft Capsules Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Etoposide Soft Capsules market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
